Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Earnings call: Zebra Technologies anticipates profitability recovery despite Q3 sales plunge

EditorAmbhini Aishwarya
Published 11/01/2023, 08:55 AM
Updated 11/01/2023, 08:55 AM
© Reuters.

Zebra Technologies reported a 30% drop in Q3 2023 sales to $956 million, attributing the decline to market softness and protracted sales cycles. Despite declines across all product categories, services and software emerged as strong performers. The company anticipates a significant sequential improvement in profitability in Q4, following cost restructuring actions projected to save $100 million annually. However, Zebra remains cautious, expecting Q4 sales to fall between 32% and 36% compared to the previous year.

Key takeaways from the call include:

  • Zebra highlighted recent wins, including a global technology provider adopting Zebra's machine vision solution and a European healthcare system utilizing Zebra's technology for real-time tracking of medical equipment.
  • The company is working with customers on budgeting and technology refreshes for 2024.
  • Supply chain costs and volume deleveraging impacted Q3 margins, but pricing actions and service/software margins have helped mitigate these effects.
  • Zebra sees growth opportunities in the healthcare and manufacturing sectors, with a focus on machine vision and robotic automation.
  • The company expects the e-commerce/retail and transportation/logistics markets to rebound, with inventory restocking following sales improvements.

Zebra Technologies has been actively addressing the challenges in their sales cycles and margins. The company is working with customers on budgeting and technology refreshes for 2024. They have also been taking steps to mitigate the impact of supply chain costs on their margins, such as rebalancing manufacturing and distribution capacity to lower volumes and pricing actions.

The company sees opportunities for future growth in the healthcare and manufacturing sectors. They are developing specific products for the healthcare market to improve productivity and patient safety. In manufacturing, the focus is on machine vision and robotic automation. Zebra Technologies (NASDAQ:ZBRA) is also shifting sales resources to manufacturing and recruiting more partners in that area.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zebra anticipates a recovery in the e-commerce/retail and transportation/logistics markets, driven by increased demand and the utilization of excess capacity. They also noted that customers are currently using assets longer but will eventually need to upgrade due to factors like older devices and the need for more advanced features.

Recent acquisitions, including Reflexis, Antuit, and Matrox, have been successful in enabling retail associates through task management, workforce management, and communication. Bill Burns, a representative from the company, expressed optimism about diversifying the offerings of Matrox into new markets like automotive and food and beverage. He also noted that Fetch and robotics automation present attractive opportunities in goods transport and e-commerce.

Despite near-term challenges, Zebra remains confident in their business and believes they are well-positioned for long-term growth. The company is grateful to their customers, partners, and employees for their continued support during these challenging times.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.